CXCL2 and experimental autoimmune encephalomyelitis: In an experimental autoimmune encephalomyelitis mouse model, ALKBH5 decreased m6A modification on interferon-γ (IFN-γ) and C-X-C motif chemokine ligand 2 (CXCL2) mRNA in CD4+ T cells, increasing the stability of mRNA transcripts and enhancing corresponding protein expression [837].